Cited by 99Alzheimer's disease research and treatmentsEpilepsy research and treatmentNeuroscience and Neuropharmacology Research

BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization

Open access
Hitt, Brian D, Jaramillo, Thomas C, Chetkovich, Dane M, Vassar, Robert·2010·Molecular Neurodegeneration

Abstract

Background: BACE1 is a key enzyme in the generation of the Aβ peptide that plays a central role in the pathogenesis of Alzheimer's disease. While BACE1 is an attractive therapeutic target, its normal physiological function remains largely unknown. Examination of BACE1-/- mice can provide insight into this function and also help anticipate consequences of BACE1 inhibition. Here we report a seizure-susceptibility phenotype that we have identified and characterized in BACE1-/- mice. Results: We find that electroencephalographic recordings reveal epileptiform abnormalities in some BACE1-/- mice, occasionally including generalized tonic-clonic and absence seizures. In addition, we find that kainic acid injection induces seizures of greater severity in BACE1-/- mice relative to BACE1+/+ littermates, and causes excitotoxic cell death in a subset of BACE1-/- mice. This hyperexcitability phenotype is variable and appears to be manifest in approximately 30% of BACE1-/- mice. Finally, examination of the expression and localization of the voltage-gated sodium channel α-subunit Na v 1.2 reveals no correlation with BACE1 genotype or any measure of seizure susceptibility. Conclusions: Our data indicate that BACE1 deficiency predisposes mice to spontaneous and pharmacologically-induced seizure activity. This finding has implications for the development of safe therapeutic strategies for reducing Aβ levels in Alzheimer's disease. Further, we demonstrate that altered sodium channel expression and axonal localization are insufficient to account for the observed effect, warranting investigation of alternative mechanisms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1326-5-31

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hitt, B. D., Jaramillo, T. C., Chetkovich, D. M., & Vassar, R.
Affiliations
Northwestern University (US)
Corresponding author
Vassar, Robert
Venue
Molecular Neurodegeneration
Published
2010-08-23
Volume
5
Issue
1
Pages
31-31
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2153669928
Cited by
99
References
59
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 13 · 2013: 13 · 2012: 6
FWCI
6.07
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Northwestern University
  • National Institutes of Health (5 -T32, NIH T32)
  • National Institute on Aging (RF1AG022560)
  • National Institute of General Medical Sciences (T32GM008061)
  • National Institute of Neurological Disorders and Stroke (K02NS055995, R21NS065391, R01NS059934)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
BACE1, seizure susceptibility, epilepsy, epileptiform abnormalities, kainic acid-induced seizures, excitotoxic cell death, axonal localization, amyloid-beta, Alzheimer's disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review